Insider · CIK 0001182615
Paul Maier V
Files at ISCO (International Stem Cell CORP), ETON (Eton Pharmaceuticals, Inc.). First filing Sep 15, 2026, latest Sep 15, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ISCO: International Stem Cell CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | ISCOsell International Stem Cell CORP | $10k 32,802 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | ISCO International Stem Cell CORP | DDisposition to issuer Stock Optionsderivative | -30,000 | $0.00 | $0 | 0 | 25 d ago |
| Sep 11, 2026 | ISCO International Stem Cell CORP | SOpen-market sale Common Stockindirect: Through family Trust dated 4/21/2000 | -32,802 | $0.32 | $10k | 0 | 27 d ago |
| Jun 17, 2025 | ISCO International Stem Cell CORP | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 20, 2025 |
| Jun 17, 2025 | ISCO International Stem Cell CORP | AGrant or award Stock Option (Right to Buy)derivative | +532,786 | $0.00 | $0 | 532,786 | Jun 20, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.